All In Biotech

Drug Trial Radar · NCT07845071

An Open-Label, Safety and Efficacy Study of Cebranopadol in Participants With Acute Pain With Surgical or Non-Surgical Origin

An Open-Label, Single-Arm, Multiple-Dose, Phase 3 Safety and Efficacy Study of Cebranopadol in Participants With Moderate to Severe Acute Pain With Surgical or Non-Surgical Origin

Last checked: Nov 20, 2026Latest source record: Oct 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

160

Planned (sponsor's estimate)

Start

Sep 22, 2026

Primary completion

Jan 2027

Study completion Feb 2027

Sponsor

Lead sponsor
Adneuris Therapeutics, Inc.Industry
Sponsor type
Industry
First posted
Sep 28, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the safety and effectiveness of cebranopadol in treating acute pain.

Conditions

  • Pain

Interventions

  • Cebranopadol 400 ugDrug

    Participants receive Cebranopadol 400 mcg once per day for 14 days or until pain resolves, whichever occurs first.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Sum of pain intensity differences through 48 hours (SPID48)Time frame: From 0 through 48 hours

Locations

15 sites in 1 country. Site status is shown where the registry gives one.

  • Adneuris Site 001115

    Phoenix, Arizona · Recruiting

  • Adneuris Site 001118

    Riverside, California · Recruiting

  • Adneuris Site 001119

    Longmont, Colorado · Recruiting

  • Adneuris Site 001122

    Savannah, Georgia · Recruiting

  • Adneuris Site 001123

    O'Fallon, Illinois · Recruiting

  • Adneuris Site 001125

    Annapolis, Maryland · Recruiting

  • Adneuris Site 001120

    Oradell, New Jersey · Recruiting

  • Adneuris Site 001124

    Tulsa, Oklahoma · Recruiting

  • Adneuris Site 001110

    Bellaire, Texas · Recruiting

  • Adneuris Site 001117

    Forney, Texas · Recruiting

  • Adneuris Site 001104

    McAllen, Texas · Recruiting

  • Adneuris Site 001116

    Plano, Texas · Recruiting

  • Adneuris Site 001111

    San Antonio, Texas · Recruiting

  • Adneuris Site 001121

    San Antonio, Texas · Recruiting

  • Adneuris Site 001101

    Salt Lake City, Utah · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.